Updated September 2026Tile and product page differClaya review
The homepage advertises one semaglutide rate and the product page charges another.
The verdict
Claya's semaglutide page prices the weekly injection at $179 a month and the tablets at $279. The homepage a click earlier advertises a lower figure for the same injection, and attributes it to multi-month plans in one place and to the monthly plan in another.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Injection
- From $179/mo
- Oral
- From $279/mo
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
Claya is a cash-pay GLP-1 service selling compounded semaglutide as a weekly injection and as a tablet, with compounded tirzepatide offered by injection. A daily drop format is described on the semaglutide page but not priced. Coaching and a patient portal are sold alongside the medication.
Who writes the prescription, and what do they see?
Every assessment is stated to be reviewed by a licensed provider, and medication is described as shipping only if a provider deems it appropriate. The intake is a three-minute form rather than a scheduled visit. No prescriber or medical group is named on the page. What a provider reads before approving is not described.
Plans are described as monthly with options shown before checkout, and the site states there is no lock-in. Refill reminders, shipping support and care-team messaging are included rather than billed. A separate membership page and a coaching program sit beside the medication. Shipping is offered same-day where a prescription clears before the pharmacy cutoff.
What happens when the dose goes up?
Claya states that dosing is adjusted as the body responds and that the same price applies regardless of dosage. That covers the money, but not the clinical side of a step up. No milligram figure appears beside either plan. Nothing published names who signs off on an increase.
What the price includes
The semaglutide product page prices the injection at $179 and the tablets at $279, and those are the figures a buyer reaches. Tirzepatide has no product page of its own and is priced only in the homepage plan block, at $199. The oral tirzepatide the catalog once carried is no longer sold. Three semaglutide formats are described and two are priced.
What it claims, and what it cites
Both molecules are offered compounded. A required safety notice states that compounded medications are regulated by state boards of pharmacy, and not evaluated by the FDA for safety or efficacy. Pharmacies are described as licensed United States facilities rather than named. The same notice sets out the thyroid warnings carried by the drug class.
Where it holds up, and where it does not
- Strength: A required safety notice states the FDA position plainly
- Strength: The same price applies at every dose
- Strength: Refill support and care-team messaging are included
- Strength: Plan options are shown before checkout
- Strength: Same-day shipping is offered where a prescription clears early
- Limitation: The homepage and the product page quote different semaglutide rates
- Limitation: Tirzepatide has no product page of its own
- Limitation: A third semaglutide format is described but never priced
- Limitation: No pharmacy or prescriber is named
What the evidence says about this kind of treatment
The assessment above is about Claya. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer who opens the product page before trusting a homepage rate.
- Wrong for
- A buyer who wants tirzepatide documented as thoroughly as semaglutide.
How Claya compares
| Seller | Who it suits | Go |
|---|---|---|
 Breeze Meds | A reader comparing a monthly rate against a prepaid block, because this seller publishes both for the same product. | See Breeze Meds → |
 June Health | Readers who want the escalation priced before enrolling rather than met in month three | See June Health → |
| HealthRX | Buyers who expect to escalate and want the later months priced | See HealthRX → |
More GLP-1 telehealth sellers reviews: YourEraYourHealthRxYucca HealthZera HealthPepton HealthBodybuilding Health+
Sponsored alternative
Bodybuilding Health+
Readers who want to start without committing a year of money
Check Bodybuilding Health+ availability →Frequently asked
- Which semaglutide price is right?
- The product page figure of $179 a month. The homepage tile quotes a lower rate and ties it to multi-month plans.
- Can I get tirzepatide as a tablet?
- Not now. Claya prices tirzepatide only as an injection, and lists no oral tirzepatide product.
- Does a higher dose cost more?
- No. The plan cards state the same price regardless of dosage, with dosing adjusted as the body responds.
- Is Claya expensive compared with other GLP-1 telehealth sellers?
- Claya publishes a starting figure of $179/mo. Across the 225 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $399 with a median of $179, which puts Claya right at the median. The other 18 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.